Publications:

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study.

The Journal Of Antimicrobial Chemotherapy

Dolling, David I DI; Dunn, David T DT; Sutherland, Katherine A KA; Pillay, Deenan D; Mbisa, Jean L JL; Parry, Chris M CM; Post, Frank A FA; Sabin, Caroline A CA; Cane, Patricia A PA; , ; ,

Publication Date: 2013-10

Variant appearance in text: CD4: L10C

PubMed Link: 23711895

Variant Present in the following documents:

• Main text
• dkt199.pdf

View BVdb publication page

Long-term treatment of patients with HIV-1: the role of atazanavir.

Hiv/Aids (Auckland, N.Z.)

Artacho, Miguel Ángel MÁ; Barreiro, Pablo P; Fernández-Montero, José Vicente JV

Publication Date: 2010

Variant appearance in text: CD4: L10C

PubMed Link: 22096394

Variant Present in the following documents:

• Main text
• hiv-2-157.pdf

View BVdb publication page

Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa.

Aids Research And Treatment

Wallis, Carole L CL; Mellors, John W JW; Venter, Willem D F WD; Sanne, Ian I; Stevens, Wendy W

Publication Date: 2011

Variant appearance in text: CD4: L10C

PubMed Link: 21490784

Variant Present in the following documents:

• ART2011-769627.pdf

View BVdb publication page

Role of atazanavir in the treatment of HIV infection.

Therapeutics And Clinical Risk Management

Rivas, Pablo P; Morello, Judit J; Garrido, Carolina C; Rodríguez-Nóvoa, Sonia S; Soriano, Vincent V

Publication Date: 2009-02

Variant appearance in text: CD4: L10C

PubMed Link: 19436623

Variant Present in the following documents:

• Main text
• tcrm-5-0099.pdf

View BVdb publication page